Literature DB >> 22529730

Multicentre clinical trials in infectious diseases in Canada.

.   

Abstract

Entities:  

Year:  1992        PMID： 22529730      PMCID： PMC3328027     

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN： 1180-2332


× No keyword cloud information.
  9 in total

1.  Prevention of rheumatic fever; treatment of the preceding streptococcic infection.

Authors:  F W DENNY; L W WANNAMAKER; W R BRINK; C H RAMMELKAMP; E A CUSTER
Journal:  J Am Med Assoc       Date:  1950-05-13

2.  Single-dose compared with 3-day norfloxacin treatment of uncomplicated urinary tract infection in women. Canadian Infectious Diseases Society Clinical Trials Study Group.

Authors:  R Saginur; L E Nicolle
Journal:  Arch Intern Med       Date:  1992-06

Review 3.  Immunizations, immunoprophylaxis, and chemoprophylaxis to prevent selected infections. US Preventive Services Task Force.

Authors:  F M LaForce
Journal:  JAMA       Date:  1987-05-08       Impact factor: 56.272

4.  A preliminary report on the use of ceftizoxime vs. clindamycin/tobramycin for the therapy of intra-abdominal and pelvic infections.

Authors:  G Harding; J Vincelette; A Rachlis; I Fong; L Mandell; R Feld; D Bailey
Journal:  J Antimicrob Chemother       Date:  1982-11       Impact factor: 5.790

5.  Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infections.

Authors:  M G Bergeron; J Mendelson; G K Harding; L Mandell; I W Fong; A Rachlis; R Chan; S Biron; R Feld; N B Segal
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

6.  A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients.

Authors:  R Feld; T J Louie; L Mandell; E J Bow; H G Robson; A Chow; A Belch; L Miedzinski; A Rachlis; J Pater
Journal:  Arch Intern Med       Date:  1985-06

7.  Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.

Authors:  L A Mandell; M G Bergeron; A R Ronald; C Vega; G Harding; R Saginur; R Feld; R Duperval; S J Landis; L J Miedzinski
Journal:  J Infect Dis       Date:  1989-09       Impact factor: 5.226

8.  A prospective randomized trial of ceftazidime versus cefazolin/tobramycin in the treatment of hospitalized patients with pneumonia.

Authors:  L A Mandell; L E Nicolle; A R Ronald; S J Landis; R Duperval; G K Harding; H G Robson; R Feld; J Vincelette; I Fong
Journal:  J Antimicrob Chemother       Date:  1987-07       Impact factor: 5.790

9.  Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study.

Authors:  R J Whitley; S J Soong; R Dolin; G J Galasso; L T Ch'ien; C A Alford
Journal:  N Engl J Med       Date:  1977-08-11       Impact factor: 91.245
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.